BP, Cardiovascular Disease, and Death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial

The optimal BP level in kidney transplant recipients remains uncertain. This post hoc analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial cohort assessed associations of BP with a pooled cardiovascular disease (CVD) outcome and with all-cause mortality. In 34...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Carpenter, Myra A., John, Alin, Weir, Matthew R., Smith, Stephen R., Hunsicker, Lawrence, Kasiske, Bertram L., Kusek, John W., Bostom, Andrew, Ivanova, Anastasia, Levey, Andrew S., Solomon, Scott, Pesavento, Todd, Weiner, Daniel E.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2014
Matèries:
Clinical Epidemiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073424/
https://ncbi.nlm.nih.gov/pubmed/24627349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013040435
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars